搜索结果

Search Results for " glun2d "

如果没找到您满意的产品或者您对产品有其他要求，可以联系我们专业顾问为您提供针对性的合理建议。 QQ咨询网站留言咨询

Cat. No.	Product Name	Target	Signaling Pathways
T22748	DQP 1105	NMDAR	Neuroscience
	DQP 1105 是一种高效非竞争性NMDA 受体拮抗剂。DQP-1105 抑制含有 GluN2C (IC50:7.0 Μm) 和 GluN2D (IC50:2.7 Μm) 的受体。 IC50值至少比重组 GluN2B-、GluN2A-、GluA1- 或 GluK2 受体低 50 倍。
T16801	(RS)-(Tetrazol-5-yl)glycine LY 285265,D,L-(tetrazol-5-yl)glycine	NMDAR; iGluR	Membrane transporter/Ion channel; Neuroscience
	(RS)-(Tetrazol-5-yl)glycine (LY 285265) 是一种高效且选择性的 N-甲基-D-天冬氨酸 (NMDA) 受体激动剂。它能够诱导小鼠癫痫发作反应和 Fos。它对 GluN1/GluN2D 和 GluN1/GluN2A 的EC50分别为 99 nM，1.7 μM。
T15407	GNE-0723	Others	Others
	GNE 0723 is an NMDAR brain permeable positive allosteric modulator (EC50: 21 nM for GluN2A; 7.4 and 6.2 μM for GluN2C and GluN2D, respectively).
T15408	GNE 5729	Others	Others
	GNE 5729 is an NMDAR of brain permeable positive allosteric modulator (EC50: 37 nM for GluN2A; 4.7 and 9.5 μM for GluN2C and GluN2D, respectively).
T24551	NSC339614 potassium NSC 339614 potassium,NSC-339614 potassium,NSC339614 potassium salt
	NSC339614 potassium is a selective GluN1/GluN2C and GluN1/GluN2D receptors potentiator.
T19881	UBP608 UBP-608,UBP 608
	UBP608 is an allosteric modulator of NMDA receptor family. It selectively inhibits GluN1/GluN2A receptors with a 23-fold selectivity compared to GluN1/GluN2D receptors.
T61227	NAB-14
	NAB-14 is a powerful and selective chemical compound that acts as a non-competitive antagonist for GluN2C and GluN2D receptors. With an IC50 value of 580 nM for GluN1/GluN2D, NAB-14 demonstrates high potency. This compound exhibits a remarkable selectivity of more than 800-fold towards recombinant GluN2C and GluN2D when compared to GluN2A and GluN2B. Furthermore, NAB-14 possesses the ability to penetrate the blood-brain-barrier effectively [1].
T73491	TP-050
	TP-050 是一种口服有效的选择性 NMDAR 激动剂，抑制 GluN2A 和 GluN2D 的 EC50值分别为 0.51 μM 和 9.6 µM。TP-050 可穿过血脑屏障 (BBB)。TP-050 诱导海马区的长期增益效应 (LTP)，增强神经元信号传输。
T79611	DQP-26	iGluR	Membrane transporter/Ion channel; Neuroscience
	DQP-26，作为一种高效的NMDAR负变构调制剂，展现出对GluN2C和GluN2D亚单位具有显著的选择性，其IC50值分别仅为0.77 μM和0.44 μM。该化合物在针对NMDAR相关神经系统疾病的研究中显示出潜在应用价值。